The cause of menstrual disorders is unknown because many female students, embarrassed or unsure of what is "normal," never seek care. In young females, abnormal uterine bleeding is usually functional-reflecting immaturity or dysregulation of the hypothalamic-pituitary-ovarian axis, anovulatory cycles, or inherited bleeding disorders-while serious structural pathology is rare. Nevertheless, early bleeding can be the first sign of conditions such as polycystic-ovary syndrome, endometriosis, or von Willebrand disease. It is the primary source of iron-deficiency anemia in females before marriage, leading to chronic fatigue, diminished academic performance, and lower exam results.
A sectional study will be performed using a semi-structured questionnaire to assess the presence of HMB using the SAMANTA scale after its Arabic validation, and also evaluate the effect of HMB on quality of life using the validated heavy menstrual bleeding scale and assess impact on academic performance finally both females with positive HMB or not will asked to do Complete blood count (CBC), serum ferritin and coagulation profile.
None
Females known to have chronic anemia or hemolytic anemia by history
Females on anticoagulation treatment.
Females known to have coagulopathy.
Females with any chronic condition (diabetes mellitus, liver diseases, etc.) in the previous 12 months were excluded from participation in this study.
Female Students in Assiut University, Egypt who accepted to share in the study
Ecologic or community
Cross-sectional
Not listed
the prevalence of heavy menstrual bleeding (HMB)
to estimate the prevalence of heavy menstrual bleeding (HMB) among Assiut university female students.
impact of heavy menstrual bleeding (HMB) on participants' quality of life and academic performance.
To evaluate the impact of heavy menstrual bleeding (HMB) on participants' quality of life and academic performance.
Hematologic (CBC indices, serum ferritin and coagulation profile) between participants
Compare hematologic (CBC indices, serum ferritin and coagulation profile) between participants with HMB and partcipants without HMB.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
